Related Experiment Videos

Parenteral trimethoprim/sulfamethoxazole for gram-negative bacillary meningitis

Insights

Intravenous trimethoprim/sulfamethoxazole effectively treated gram-negative bacillary meningitis in three adults, sterilizing cerebrospinal fluid. This antibiotic combination shows promise for managing serious central nervous system infections.

Area of Science:

  • Infectious Diseases
  • Neuroscience
  • Pharmacology

Background:

  • Gram-negative bacillary meningitis is a severe central nervous system infection.
  • Treatment options for gram-negative meningitis can be limited, especially in post-neurosurgical or trauma cases.
  • Trimethoprim/sulfamethoxazole is a combination antibiotic with broad-spectrum activity.

Observation:

  • Three adult patients with gram-negative bacillary meningitis were treated with intravenous trimethoprim/sulfamethoxazole.
  • Infections arose as complications of neurosurgery, trauma, and chronic otitis media.
  • Causative organisms included Serratia marcescens and Proteus vulgaris.

Findings:

  • Intravenous trimethoprim/sulfamethoxazole therapy sterilized cerebrospinal fluid in all three patients.
  • The infecting organisms were eradicated within 3 to 17 days.
  • Follow-up cerebrospinal fluid cultures were sterile after treatment completion.

Implications:

  • Intravenous trimethoprim/sulfamethoxazole may be an effective treatment for specific cases of gram-negative bacillary meningitis.
  • This regimen could be a valuable option for meningitis complicating neurosurgery, trauma, or otitis media.
  • Further clinical studies are warranted to confirm the efficacy and safety of this treatment approach.

Related Concept Videos